ELEX BIOTECH, LLC

Address

2828 SW CORBETT AVE, STE 140A
PORTLAND, OR, 97201-4830

http://www.elexbiotech.com

Information

DUNS: 832476803
# of Employees: 2

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Development of novel compounds for the treatment of atrial fibrillation

    Amount: $427,638.00

    DESCRIPTION provided by applicant Atrial fibrillation AF is the most prevalent type of cardiac arrhythmia in the developed world affecting million people in the United States alone a number t ...

    STTRPhase I2015Department of Health and Human Services
  2. Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT

    Amount: $1,500,383.00

    DESCRIPTION provided by applicant Abstract Current therapies to treat the orphan disease catecholaminergic polymorphic ventricular tachycardia CPVT have potential side effects so severe that ho ...

    STTRPhase II2015Department of Health and Human Services
  3. Rational Design of New Drugs to Treat Ventricular Arrhythmias

    Amount: $349,774.00

    DESCRIPTION (provided by applicant): Sudden cardiac death (SCD) is a major cause of death, responsible for greater than 300,000 adult deaths per year in the United States alone. Cardiac arrest and SCD ...

    STTRPhase I2012Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government